ISDA

Entry Detail

PDB ID:

8RUU

Keywords:

IMMUNOSUPPRESSANT

Title:

Fabs derived from bimekizumab in complex with IL-17F

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Cricetulus griseus

PDB Version:

Deposition Date:

2024-01-31

Release Date:

2024-04-24

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.81 Å

R-Value Free:

0.24

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Polymer Type:polypeptide(L)
Description:Immunoblobulin heavy chain
Chain IDs:A (auth: B), D (auth: H)
Chain Length:228
Number of Molecules:2
Biological Source:Homo sapiens

Polymer Type:polypeptide(L)
Description:Immunoblobulin light chain
Chain IDs:B (auth: C), E (auth: L)
Chain Length:214
Number of Molecules:2
Biological Source:Homo sapiens

Protein Blast

Polymer Type:polypeptide(L)
Description:Interleukin-17F
Chain IDs:C (auth: X), F (auth: Y)
Chain Length:133
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q96PD4 Pfam ID:PF06083

Ligand Molecules

NAG

Primary Citation

Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition.

Adams, R, Bunick, C.G, Lawson, A.D.G, Gomez, B, Shaw, S, Afonine, P.V, Grosse-Kunstleve, R.W, Echols, N, Headd, J.J, Moriarty, N.W, Mustyakimov, M, Terwilliger, T.C, Urzhumtsev, A, Zwart, P.H, Adams, P.D, Liebschner, D, Afonine, P.V, Baker, M.L, Bunkoczi, G, Chen, V.B, Croll, T.I, Hintze, B, Hung, L.W, Jain, S, McCoy, A.J, Moriarty, N.W, Oeffner, R.D, Poon, B.K, Prisant, M.G, Read, R.J, Richardson, J.S, Richardson, D.C, Sammito, M.D, Sobolev, O.V, Stockwell, D.H, Terwilliger, T.C, Urzhumtsev, A.G, Videau, L.L, Williams, C.J, Adams, P.D.Show

J Invest Dermatol. 144 2581 ? (2024)

PMID: 38631666 DOI: 10.1016/j.jid.2024.03.037

Primary Citation of related structures